ESTRO 38 - Programme Book & Exhibition Guide

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

TUESDAY 30 APRIL 2019

DEBATE This house believes that immunotherapy is really changing radiation oncology 11:00 - 12:15 | Brown 1 Chair: A. Chalmers (United Kingdom) Co-chair: R. Baumann (Germany)

11:00 > For the motion

Speaker: E. Deutsch (France)

SP-0685

11:15 > Against the motion

Speaker: M. Baumann (Germany), N. Ebert

SP-0686

11:30 > For the motion: combining radiotherapy with immunotherapy: focus on immunocytokines Speaker: P. Lambin (The Netherlands), R. Lieverse, E.J. Van Limbergen, V. Olivo Pimentel, D. Marcus, A. Van Der Wiel, J. Theys, A. Yaromina, L.J. Dubois, A. Hoeben, A.M. Dingemans 11:45 > Against the motion: we don't need Costalotamab when we have SBRT Speaker: M. Joiner (USA)

SP-0687

SP-0688

12:00 > Discussion

DEBATE This house believes that patients with squamous cell cancer of the esophagus no longer need surgery 11:00 - 12:15 | Auditorium Efficacy of chemoradiotherapy (CRT) in esophageal squamous cell carcinoma (SCC) will be discussed, with focus on potential subgroups of patients that could benefit from definitive CRT (dCRT) as an organ- sparing approach, the need for a prediction model for histopathological response, and quality of life after dCRT and surgery. Locoregional control and overall survival in SCC patients will be compared between dCRT and neoadjuvant CRT + surgery. Role of surgery in poor-responders and as salvage treatment will be discussed. Current approaches across Europe contrasting use of surgery +/- neoadjuvant therapies vs dCRT will be outlined.

Chair: C. Belka (Germany) Co-chair: J. Socha (Poland)

11:00 > For the motion

Speaker: F. Cellini (Italy)

SP-0689

Programme and Exhibition Guide | SCIENTIFIC PROGRAMME

187